This is not the most recent version of the article. View current version (11 MAY 2015)

Intervention Protocol

You have free access to this content

Chelation for autism spectrum disorder (ASD)

  1. Stephen James1,*,
  2. Katrina Williams2,3,4,
  3. Natalie Silove5,
  4. Shawn W Stevenson6

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 11 OCT 2013

DOI: 10.1002/14651858.CD010766


How to Cite

James S, Williams K, Silove N, Stevenson SW. Chelation for autism spectrum disorder (ASD) (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010766. DOI: 10.1002/14651858.CD010766.

Author Information

  1. 1

    Arizona State University, School of Social Work, Phoenix, Arizona, USA

  2. 2

    University of Melbourne, Department of Paediatrics, Parkville, Victoria, Australia

  3. 3

    Royal Children's Hospital, Department of Developmental Medicine, Parkville, Victoria, Australia

  4. 4

    Murdoch Childrens Research Institute, Parkville, Victoria, Australia

  5. 5

    The Children's Hospital at Westmead, Child Development Unit, Westmead, New South Wales, Australia

  6. 6

    University of Melbourne, The Royal Children's Hospital, Department of Paediatrics, Parkville, Victoria, Australia

*Stephen James, School of Social Work, Arizona State University, 411 N. Central Avenue, Suite 800, Phoenix, Arizona, 85004-0689, USA. stephen.james@green.oxon.org. stephen.nicholas.james@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 11 OCT 2013

SEARCH

This is not the most recent version of the article. View current version (11 MAY 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the potential benefits and adverse effects of chelation for ASD symptomatology.